Application 040859
- Type
- ANDA
- Sponsor
- BAXTER HLTHCARE CORP
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | NOREPINEPHRINE BITARTRATE | NOREPINEPHRINE BITARTRATE | INJECTABLE;INJECTION | EQ 1MG BASE/ML | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 36000-162 | Norepinephrine bitartrate | Norepinephrine bitartrate | Baxter Healthcare Corporation | ANDA | Current |
| 36000-162 | Norepinephrine bitartrate | Norepinephrine bitartrate | Baxter Healthcare Corporation | ANDA | Current |
| 36000-162 | Norepinephrine bitartrate | Norepinephrine bitartrate | Baxter Healthcare Corporation | ANDA | Current |
| 36000-162 | Norepinephrine bitartrate | Norepinephrine bitartrate | Baxter Healthcare Corporation | ANDA | Current |
| 36000-162 | Norepinephrine bitartrate | Norepinephrine bitartrate | Baxter Healthcare Corporation | ANDA | Current |